Novavax, Inc.

Novavax, Inc.

NVAX

Market Cap$1.19B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Novavax, Inc.Novavax, Inc.2.5--633%1-4.9
$24.78

Current Fair Value

254.6% upside

Undervalued by 254.6% based on the discounted cash flow analysis.

Share Statistics

Market cap$1.19 Billion
Enterprise Value$1.30 Billion
Dividend Yield$0 (0%)
Earnings per Share$-1.23
Beta3.21
Outstanding Shares161,049,000

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio2.47
PEG-0.55
Price to Sales1.0
Price to Book Ratio-6.99
Enterprise Value to Revenue1.03
Enterprise Value to EBIT2.72
Enterprise Value to Net Income2
Total Debt to Enterprise0.29
Debt to Equity-4.91

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Novavax, Inc.

CEO: Stanley Erck